Six-year follow-up after Helicobacter pylori eradication in peptic ulcer disease
| Autor: | B. Flynn, C. N. McGee, H. J. O’Connor, R. Walsh, C. Stewart |
|---|---|
| Rok vydání: | 2001 |
| Předmět: |
Male
medicine.medical_specialty Peptic Ulcer Time Factors Urea breath test macromolecular substances Disease Gastroenterology Epigastric pain Helicobacter Infections Recurrence Internal medicine medicine Humans medicine.diagnostic_test Helicobacter pylori business.industry digestive oral and skin physiology General Medicine Middle Aged bacterial infections and mycoses medicine.disease Anti-Ulcer Agents humanities digestive system diseases Peptic ulcer Drug Therapy Combination Female business Follow-Up Studies |
| Zdroj: | Irish journal of medical science. 170(1) |
| ISSN: | 0021-1265 |
| Popis: | The longterm outlook after Helicobacter pylori (H. pylori) eradication in peptic ulcer disease is unclear.This study documents H. pylori recurrence, dyspeptic symptoms and anti-secretory therapy in peptic ulcer patients six years or more after H. pylori eradication.Peptic ulcer patients with H. pylori eradication between 1990 and 1992 were included. Infection recurrence was diagnosed by 13-carbon urea breath test (UBT). Dyspeptic symptoms and anti-secretory therapy use were assessed by questionnaire.Sixty-one patients completed the study protocol. Mean follow-up after eradication was 6.1 years (range 4.8-8.3). Four patients had a positive UBT. H. pylori recurrence rate was 6.6% or 0.02% per patient per year. Forty-two patients (69%) had dyspeptic symptoms. Heartburn and belching were more common than pain (p0.001). All four patients with H. pylori recurrence had symptoms compared with 38 of 57 H. pylori-negative patients (p0.05). Ten of 61 patients (16.4%) were taking anti-secretory therapy and their dyspepsia scores were higher.Despite a low H. pylori recurrence rate, longterm dyspeptic symptoms were common in peptic ulcer patients after H. pylori eradication. The symptoms are mainly reflux in type and require anti-secretory therapy in only a minority of patients. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full text from SpringerLink